Company / Free Cash Flow
ClearPoint Neuro, Inc. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$24.4M
FY2025
5-year range
-$24.4M / -$12.9M
FY2021-FY2025
Trend
-69.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has fluctuated over the past 10 years, ranging from -$24M in FY2025 to -$3M in FY2019.
Based on SEC 10-K filings.
-$24M in FY2025.
Declined from -$14M to -$24M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow decreased 69.3% year-over-year.
- Peak free cash flow was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.71 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$24.4M | -69.3% |
| FY2024 | -$14.4M | +0.0% |
| FY2023 | -$14.4M | +12.1% |
| FY2022 | -$16.4M | -27.6% |
| FY2021 | -$12.9M | -63.9% |
| FY2020 | -$7.8M | -174.4% |
| FY2019 | -$2.9M | +39.1% |
| FY2018 | -$4.7M | +22.0% |
| FY2017 | -$6.0M | -1.7% |
| FY2016 | -$5.9M | +32.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026